Jianchun Duan

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Shanxi Provincial Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences · ORCID：0000-0003-3300-1707

发表论文 127 篇 · 总被引 3546 次 · h-index 25

代表论文

• Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR ‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS) (2024 · 癌症：英文版 · 被引 28)
• A single-cell characterised signature integrating heterogeneity and microenvironment of lung adenocarcinoma for prognostic stratification (2024 · EBioMedicine · 被引 25)
• Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer (2024 · Cancer Cell · 被引 22)
• Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy (2024 · Nature Communications · 被引 21)
• OA04.06 Efficacy and Safety of HS-20093 in Extensive Stage Small Cell Lung Cancer in A Multicenter, Phase 1 Study (ARTEMIS-001) (2024 · Journal of Thoracic Oncology · 被引 12)
• Uncommon/rare oncogenic drivers in non‐small cell lung cancer: Consensus and contention (2023 · Medicine Advances · 被引 9)